DaVita (DVA +2.5%) is up on below-average volume in apparent response to a report from Capital Forum that the Federal Trade Commission (FTC) staff reviewing the planned sale of its Medical Group unit to UnitedHealth (UNH +1.7%) will give a thumbs up on the $4.34B deal.
Date: June 10, 2019
Source: Seeking Alpha